PDS BIOTECHNOLOGY CORP PDSB
COM · Common Stock · CUSIP 70465T107
Company in Lawrenceburg, United States
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersPrinceton, NJ
- Websitepdsbiotech.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($4.4m this quarter). Holder counts are more reliable. Shares outstanding: 28.4m as of 2021-08-06, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $13.60. Options: 6 managers hold calls ($2.7m notional), 6 hold puts ($3.9m).
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 22 |
| Q1 2020 | 29 |
| Q2 2020 | 26 |
| Q3 2020 | 32 |
| Q4 2020 | 31 |
| Q1 2021 | 33 |
| Q2 2021 | 47 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 12 | 6 |
| Q2 2020 | 10 | 12 |
| Q3 2020 | 18 | 7 |
| Q4 2020 | 13 | 10 |
| Q1 2021 | 20 | 15 |
| Q2 2021 | 34 | 16 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2020 | $0 | $0 | — |
| Q4 2020 | $0 | $0 | — |
| Q1 2021 | $0 | $0 | — |
| Q2 2021 | $2.7m | $3.9m | 1.42 |
Biggest buyers
| AIGH Capital Management LLC | New | +1.5m |
| BlackRock Inc. | Added | +358.6k |
| Worth Venture Partners, LLC | New | +348.7k |
| Informed Momentum Co LLC | New | +279.6k |
| Global IMC LLC | New | +187.9k |
| Maven Securities LTD | New | +161.3k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | +127.3k |
| VANGUARD GROUP INC | Added | +102.5k |
| CITADEL ADVISORS LLC | New | +88.4k |
| Monashee Investment Management LLC | New | +80.0k |
Biggest sellers
| Ikarian Capital, LLC | Sold out | -383.4k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -212.3k |
| Minot Wealth Management LLC | Sold out | -45.4k |
| MARSHALL WACE, LLP | Sold out | -44.2k |
| BOOTHBAY FUND MANAGEMENT, LLC | Sold out | -42.9k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -21.1k |
| GOLDMAN SACHS GROUP INC | Sold out | -20.9k |
| Tower Research Capital LLC (TRC) | Reduced | -20.3k |
| LINCOLN NATIONAL CORP | Sold out | -16.6k |
| Virtu Financial LLC | Sold out | -10.6k |
Biggest calls
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $2.0m156.3k shares |
| CITADEL ADVISORS LLC | New | $646.0k51.5k shares |
| SIMPLEX TRADING, LLC | New | $133.0k10.6k shares |
| GROUP ONE TRADING LLC | New | $3.0k200 shares |
| Cutler Group LLC / CA | New | $2.0k1.1k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $2.6m204.7k shares |
| CITADEL ADVISORS LLC | New | $1.2m99.0k shares |
| SIMPLEX TRADING, LLC | New | $82.0k6.6k shares |
| GROUP ONE TRADING LLC | New | $5.0k400 shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
| Cutler Group LLC / CA | New | $01.2k shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Nant Capital, LLC
13D · may seek influence
new · filed 2026-09-21
Stated purposeThe information set forth in Item 3 of this Schedule is incorporated herein by reference. The Reporting Person acquired their shares of Common Stock, Pre-Funded Warrants and Common Warrants as an investment in the ordinary course of business. At the Milestone Closing, which will be triggered by the Issuer's submission of a registrational Phase 3 clinical trial protocol for PDS0301 designed in collaboration with Nant Capital to the U.S. Food & Drug Administration (the "Milestone Event"), Nant Capital, along with certain other PIPE Investors, will be obligated to purchase and the Issuer will be obligated to issue to Nant Capital shares of Comon Stock or Pre-Funded Warrants in lieu thereof for an aggregate subscription amount of $10,000,000. The purchase price per share of Common Stock at th… Full filing |
19.9% |
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2019 | 0 | — | 0 | — | — |
| Q4 2019 | 0 | — | 0 | — | — |
| Q1 2020 | 0 | — | 0 | — | — |
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 4 | $300.0k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2021-06-16 | Bloomquist DeLyle W See Remarks | Bought | $98.8k10.0k shares |
| 2021-06-15 | VAN VOORHEES SETH Chief Financial Officer | Bought | $150.0k17.6k shares |
| 2021-06-15 | Ali-Jackson Kamil Director | Bought | $100.0k11.8k shares |
| 2021-06-15 | Freitag Gregory Gene Director | Bought | $50.0k5.9k shares |
| 2021-06-15 | Glover Steve C Director | Bought | $50.0k5.9k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| AIGH Capital Management LLC 5.10% of their portfolio | 1.5m $18.8m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 963.5k $12.1m | Added +102.5k |
| RENAISSANCE TECHNOLOGIES LLC 0.01% of their portfolio | 455.5k $5.7m | Reduced -212.3k |
| BlackRock Inc. 0.00% of their portfolio | 401.4k $5.0m | Added +358.6k |
| Worth Venture Partners, LLC 1.63% of their portfolio | 348.7k $4.4m | New |
| Informed Momentum Co LLC 0.54% of their portfolio | 279.6k $3.5m | New |
| INSPIRION WEALTH ADVISORS, LLC 0.78% of their portfolio | 253.3k $3.2m | Added +4.3k |
| Global IMC LLC 0.65% of their portfolio | 187.9k $2.4m | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 177.9k $2.2m | Added +7.8k |
| FIRST MANHATTAN CO. LLC. 0.01% of their portfolio | 172.9k $2.2m | Added +23.9k |
| Maven Securities LTD 0.20% of their portfolio | 161.3k $1.9m | New |
| Sofinnova Investments, Inc. 0.11% of their portfolio | 142.6k $1.8m | Unchanged |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 127.3k $1.6m | New |
| New Leaf Venture Partners, L.L.C. 2.05% of their portfolio | 117.2k $8.0m | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 88.4k $1.1m | New |
| Monashee Investment Management LLC 0.12% of their portfolio | 80.0k $1.0m | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 69.1k $867.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 65.7k $825.0k | Added +62.9k |
| Laurion Capital Management LP 0.01% of their portfolio | 62.9k $789.0k | New |
| STATE STREET CORP 0.00% of their portfolio | 59.2k $743.0k | New |
| LPL Financial LLC 0.00% of their portfolio | 51.0k $641.0k | New |
| ACT CAPITAL MANAGEMENT, LLC 0.29% of their portfolio | 45.0k $565.0k | First filing |
| Bank of New York Mellon Corp 0.00% of their portfolio | 38.8k $486.0k | Added +4.9k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 36.3k $455.0k | Unchanged |
| Andesa Financial Management Inc. 0.13% of their portfolio | 33.3k $418.0k | Unchanged |
| Iron Gate Global Advisors LLC 0.09% of their portfolio | 25.2k $316.0k | New |
| 683 Capital Management, LLC 0.02% of their portfolio | 25.0k $314.0k | New |
| Cubist Systematic Strategies, LLC 0.00% of their portfolio | 25.0k $313.0k | New |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.00% of their portfolio | 13.0k $163.0k | New |
| OPPENHEIMER & CO INC 0.00% of their portfolio | 12.6k $158.0k | New |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 6.7k $83.0k | New |
| Ellis Investment Partners, LLC 0.02% of their portfolio | 6.2k $78.0k | Reduced -1.5k |
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 6.2k $77.0k | New |
| RBC Europe Ltd 0.00% of their portfolio | 6.2k $77.2k | Added +1.5k |
| Dorsey Wright & Associates 0.01% of their portfolio | 4.1k $51.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.2k $40.0k | Reduced -20.3k |
| Cutler Group LLC / CA 0.00% of their portfolio | 2.9k $36.0k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 2.5k $32.0k | Added +1.0k |
| CITIGROUP INC 0.00% of their portfolio | 1.0k $13.0k | New |
| Truvestments Capital LLC 0.00% of their portfolio | 655 $8.0k | Unchanged |
| Arkadios Wealth Advisors 0.00% of their portfolio | 500 $6.0k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 205 $2.0k | Added +99 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 123 $2.0k | Reduced -1 |
| FEDERATED HERMES, INC. 0.00% of their portfolio | 108 $1.0k | Not comparable |
| IFP Advisors, Inc 0.00% of their portfolio | 11 $0 | New |
| FMR LLC 0.00% of their portfolio | 1 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |